-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...

Does long-term intake of a special form of insulin prevent diabetes and heart problems, but cause cancer? The debate has been raging in medical circles for long. Now, an international study involving 12,000 pre-diabetics settles two parts of it, but leaves the other open for further research. Results of ORIGIN (Outcome Reduction with Initial Glargine Intervention) study presented in the wee hours of Tuesday at the annual meeting of the American...

Commission accepts staggered relief payment proposed by State government The Kerala government has partially complied with the orders of the National Human Rights Commission (NHRC) on payment of compensation to families of those killed due to the effects of pesticide Endosulfan, and those who were physically affected. It has also submitted a report to the Commission. The State government has said that regarding payment of Rs. 5 lakh to the bedridden/victims unable to...

-The Times of India KOZHIKODE: The National Rural Health Mission (NRHM) has appointed 42 additional doctors in the rural areas on temporary basis in the wake of rain-related DISEases being reported from various parts of the district, according to NRHM district programme manager Dr A Baburaj. The doctors thus appointed on an emergency basis have been posted through the NRHM under the compulsory rural service scheme of the state government. The appointments were...

London, June 11: An investigation has exposed the organised criminals who secretly trade organs for British transplant patients for as little as £4,500 (Rs 3.85 lakh). The gangs, operating in eastern Europe and the Indian subcontinent, prey on the desperation of patients requiring organs and the poverty of donors who often earn less than £1,000 (Rs 85,754) from the exploitative deals. The so-called organ brokers have developed a network of corrupt officials...